Aperio Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Aperio Group's INSY Position: Q3 2019 in Review
Aperio Group sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 1,493 shares.
Aperio Group first reported a position in INSY in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.
- Aperio Group reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Aperio Group sold 1,493 Insys Therapeutics, Inc. shares in Q3 2019.
- Aperio Group first reported a position in Insys Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
- Aperio Group's Insys Therapeutics, Inc. position peaked at $0 in Q2 2019.
- 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.
Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.